This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Lymphoma

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The term lymphoma describes any neoplastic disorder of lymphoid tissue. Malignant lymphomas fall into two groups:

  • Hodgkin's disease or Hodgkin's lymphoma
  • non-Hodgkin's lymphoma

Major differences exist between the two:

  • age - bimodal distribution in Hodgkin's, many are young; median age of 50 in non-Hodgkin's, increasing with age
  • mode of spread - predictable in Hodgkin's, spread is step-by-step to contiguous lymph nodes, usually starting in the neck; spread is random in Non-Hodgkin's
  • histology - polymorphic in Hodgkin's, with diagnostic Reed-Sternberg cells often outnumbered by reactive cells, especially eosinophils; Non-Hodgkin's is monomorphic, with malignant cells most numerous
  • prognosis - up to 80% of Hodgkin's lymphomas are potentially curable; this proportion is much less for Non-Hodgkin's patients taken as a whole

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.